GeneFab
Philip Lee has a strong background in bioengineering and chemical engineering. Philip has held various leadership roles in companies such as GeneFab, Senti Biosciences, Merck KGaA, and EMD Millipore. As a co-founder and CEO of CellASIC, Philip pioneered microfluidic cell culture systems. With a Ph.D. in Bioengineering from the University of California, Berkeley, Philip has extensive experience in research and development in the biotechnology field.
This person is not in any offices
GeneFab
GeneFab offers its customers an extensive technology platform and know-how that spans early stage product design, technical development, and cGMP compliant production. GeneFab's technology platform includes bioinformatic-guided discovery of cell type promoters, directed evolution of small molecule-regulated gene switches, and the engineering of highly sensitive kill switches for enhanced safety and control of cellular therapies.